UPDATE 4-UnitedHealth: New hepatitis C drug costs far more than forecast
April 17, 2014 at 14:28 PM EDT
April 17 (Reuters) - UnitedHealth Group Inc, the largest U.S. health insurer, said it spent more than $100 million to cover a pricey new hepatitis C drug from Gilead Sciences Inc in its first three months on the market, an amount that was "multiple" times what it had expected.